National Facility for Translational Medicine[Grants and Funding] - Search Results

Year	Number of Results
2021	4
2022	20
2023	18
2024	8

1

Gao Z, Sheng T, Zhang W, Feng H, Yu J, Gu Z, Zhang Y. Gao Z, et al. Adv Sci (Weinh). 2024 Feb;11(8):e2304124. doi: 10.1002/advs.202304124. Epub 2023 Oct 30. Adv Sci (Weinh). 2024. PMID: 37899686 Free PMC article. Review.

2

Targeted Reprogramming of Vitamin B₃ Metabolism as a Nanotherapeutic Strategy towards Chemoresistant Cancers.

Guo D, Ji X, Xie H, Ma J, Xu C, Zhou Y, Chen N, Wang H, Fan C, Song H. Guo D, et al. Adv Mater. 2023 Sep;35(36):e2301257. doi: 10.1002/adma.202301257. Epub 2023 Jul 23. Adv Mater. 2023. PMID: 37262365

3

Protein-Mimicking Nanoparticles in Biosystems.

Ji X, Li Q, Song H, Fan C. Ji X, et al. Adv Mater. 2022 Sep;34(37):e2201562. doi: 10.1002/adma.202201562. Epub 2022 Aug 10. Adv Mater. 2022. PMID: 35576606 Review.

4

Functional Amyloids: The Biomaterials of Tomorrow?

Peña-Díaz S, Olsen WP, Wang H, Otzen DE. Peña-Díaz S, et al. Adv Mater. 2024 May;36(18):e2312823. doi: 10.1002/adma.202312823. Epub 2024 Feb 2. Adv Mater. 2024. PMID: 38308110 Review.

5

Reshaping Intratumoral Mononuclear Phagocytes with Antibody-Opsonized Immunometabolic Nanoparticles.

Liu C, Zhou Y, Guo D, Huang Y, Ji X, Li Q, Chen N, Fan C, Song H. Liu C, et al. Adv Sci (Weinh). 2023 Dec;10(34):e2303298. doi: 10.1002/advs.202303298. Epub 2023 Oct 22. Adv Sci (Weinh). 2023. PMID: 37867225 Free PMC article.

6

Ultrarapid-Acting Microneedles for Immediate Delivery of Biotherapeutics.

You J, Yang C, Han J, Wang H, Zhang W, Zhang Y, Lu Z, Wang S, Cai R, Li H, Yu J, Gao J, Zhang Y, Gu Z. You J, et al. Adv Mater. 2023 Nov;35(45):e2304582. doi: 10.1002/adma.202304582. Epub 2023 Oct 11. Adv Mater. 2023. PMID: 37547966

7

Hollow Nanomaterials in Advanced Drug Delivery Systems: From Single- to Multiple Shells.

Li Z, Xu K, Qin L, Zhao D, Yang N, Wang D, Yang Y. Li Z, et al. Adv Mater. 2023 Mar;35(12):e2203890. doi: 10.1002/adma.202203890. Epub 2023 Jan 29. Adv Mater. 2023. PMID: 35998336 Review.

8

PDX-1: A Promising Therapeutic Target to Reverse Diabetes.

Zhang Y, Fang X, Wei J, Miao R, Wu H, Ma K, Tian J. Zhang Y, et al. Biomolecules. 2022 Nov 30;12(12):1785. doi: 10.3390/biom12121785. Biomolecules. 2022. PMID: 36551213 Free PMC article. Review.

9

Homotypic targeting of immunomodulatory nanoparticles for enhanced peripheral and central immunity.

Shen Y, Guo D, Ji X, Zhou Y, Liu S, Huang J, Song H. Shen Y, et al. Cell Prolif. 2022 Mar;55(3):e13192. doi: 10.1111/cpr.13192. Epub 2022 Jan 27. Cell Prolif. 2022. PMID: 35084069 Free PMC article.

10

Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention.

Shao Y, Chen S, Han L, Liu J. Shao Y, et al. Nutr Metab (Lond). 2023 Jul 6;20(1):30. doi: 10.1186/s12986-023-00748-x. Nutr Metab (Lond). 2023. PMID: 37415199 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

47 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year